The Therapeutic Effect of the Chinese Herbal Medicine, Rehmanniae Radix Preparata, in Attention Deficit Hyperactivity Disorder via Reversal of Structural Abnormalities in the Cortex
- PMID: 30405737
- PMCID: PMC6204205
- DOI: 10.1155/2018/3052058
The Therapeutic Effect of the Chinese Herbal Medicine, Rehmanniae Radix Preparata, in Attention Deficit Hyperactivity Disorder via Reversal of Structural Abnormalities in the Cortex
Abstract
Rehmanniae radix preparata is extracted from wine-steaming the Rehmannia root, a scrophulariaceae plant. It has been used for thousands of years with effects of nourishing kidney-yin, benefiting essence and filling marrow based on traditional Chinese medicine (TCM) theory. Rehmanniae radix preparata has antioxidant, antisenescence, anti-inflammatory, and neuroprotective properties. It is the most popular Traditional Chinese medicinal compound (TCMC) used in attention deficit hyperactivity disorder (ADHD) therapy. However, few studies have been conducted exploring the effects and potential mechanisms of Rehmanniae radix preparata alone on ADHD. Recent studies have shown that Rehmanniae radix preparata inhibits spontaneous activity in mice, improves learning and memory in rats following thalamic arcuate nucleus injury, and exhibits antidepressant effects. Catalpol, an active component of Rehmanniae radix preparata, elevates brain-derived neurotrophic factor (BDNF), and attenuates neuronal apoptosis and energy metabolism failure. ADHD is characterized by hyperactivity-impulsivity and impairments in learning and memory. Its pathomechanism is closely related to structural abnormalities in the cortex that is mediated by dysfunction in neuronal development, apoptosis, and energy metabolism. We hypothesize that Rehmanniae radix preparata may be effective at treating ADHD by alleviating neurodevelopmental abnormalities, neuronal apoptosis, and energy metabolism failure.
Figures


Similar articles
-
[National physician master Jin Shiyuan's dispensing technology of Rehmanniae Radix Praeparata based on Li Shizhen's pharmaceutical academic thought].Zhongguo Zhong Yao Za Zhi. 2016 May;41(9):1759-1762. doi: 10.4268/cjcmm20160930. Zhongguo Zhong Yao Za Zhi. 2016. PMID: 28891630 Chinese.
-
Rehmanniae Radix Preparata ameliorates behavioral deficits and hippocampal neurodevelopmental abnormalities in ADHD rat model.Front Neurosci. 2024 May 30;18:1402056. doi: 10.3389/fnins.2024.1402056. eCollection 2024. Front Neurosci. 2024. PMID: 38872946 Free PMC article.
-
A systematic review on botany, processing, application, phytochemistry and pharmacological action of Radix Rehmnniae.J Ethnopharmacol. 2022 Mar 1;285:114820. doi: 10.1016/j.jep.2021.114820. Epub 2021 Nov 10. J Ethnopharmacol. 2022. PMID: 34767834
-
Variation of main components according to the number of steaming and drying of Rehmanniae radix preparata.J Pharmacopuncture. 2018 Jun;21(2):112-119. doi: 10.3831/KPI.2018.21.014. Epub 2018 Jun 30. J Pharmacopuncture. 2018. PMID: 30151312 Free PMC article.
-
Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology.J Ethnopharmacol. 2017 Feb 23;198:351-362. doi: 10.1016/j.jep.2017.01.021. Epub 2017 Jan 19. J Ethnopharmacol. 2017. PMID: 28111216 Review.
Cited by
-
Traditional Chinese Medicine Jiuwei Zhenxin Granules in Treating Depression: An Overview.Neuropsychiatr Dis Treat. 2020 Oct 2;16:2237-2255. doi: 10.2147/NDT.S273324. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 33116523 Free PMC article. Review.
-
Target Identification of Active Constituents of Shen Qi Wan to Treat Kidney Yang Deficiency Using Computational Target Fishing and Network Pharmacology.Front Pharmacol. 2019 Jun 7;10:650. doi: 10.3389/fphar.2019.00650. eCollection 2019. Front Pharmacol. 2019. PMID: 31275142 Free PMC article.
-
Effect of Dihuang Yinzi on Inflammatory Response in Cerebral Ischemia-Reperfusion Model Rats by Regulating Gut Microbiota.Biomed Res Int. 2022 Aug 17;2022:3768880. doi: 10.1155/2022/3768880. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Jan 9;2024:9849728. doi: 10.1155/2024/9849728. PMID: 36033571 Free PMC article. Retracted.
-
"Jing-Ning Granules" Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways.Evid Based Complement Alternat Med. 2022 Oct 28;2022:9139841. doi: 10.1155/2022/9139841. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36337583 Free PMC article.
-
Evaluating stability and bioactivity of Rehmannia-derived nanovesicles during storage.Sci Rep. 2024 Aug 28;14(1):19966. doi: 10.1038/s41598-024-70334-5. Sci Rep. 2024. PMID: 39198513 Free PMC article.
References
-
- Polanczyk G. V., Salum G. A., Sugaya L. S., Caye A., Rohde L. A. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of Child Psychology and Psychiatry and Allied Disciplines. 2015;56(3):345–365. doi: 10.1111/jcpp.12381. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases